Supplementary Table 5.
The Kappa scores and the numbers of common genes between each pair of consensus T2D pathways.
| KEGG ID | KEGG name | KEGG ID | KEGG name | Kappa score | Common gene number |
|---|---|---|---|---|---|
| 05214 | Glioma | 05223 | Nonsmall cell lung cancer | 0.674842 | 41 |
| 05212 | Pancreatic cancer | 05220 | Chronic myeloid leukemia | 0.585755 | 41 |
| 05214 | Glioma | 05220 | Chronic myeloid leukemia | 0.560827 | 39 |
| 05214 | Glioma | 05215 | Prostate cancer | 0.553567 | 43 |
| 04012 | ErbB signaling pathway | 05214 | Glioma | 0.547740 | 42 |
| 05212 | Pancreatic cancer | 05223 | Nonsmall cell lung cancer | 0.536905 | 33 |
| 05220 | Chronic myeloid leukemia | 05221 | Acute myeloid leukemia | 0.534126 | 35 |
| 05220 | Chronic myeloid leukemia | 05223 | Nonsmall cell lung cancer | 0.522735 | 34 |
| 05215 | Prostate cancer | 05223 | Nonsmall cell lung cancer | 0.505403 | 37 |
| 04012 | ErbB signaling pathway | 05220 | Chronic myeloid leukemia | 0.494162 | 40 |
| 05215 | Prostate cancer | 05221 | Acute myeloid leukemia | 0.487980 | 36 |
| 05215 | Prostate cancer | 05220 | Chronic myeloid leukemia | 0.487857 | 40 |
| 04012 | ErbB signaling pathway | 05223 | Nonsmall cell lung cancer | 0.470279 | 34 |
| 05221 | Acute myeloid leukemia | 05223 | Nonsmall cell lung cancer | 0.455708 | 26 |
| 05212 | Pancreatic cancer | 05214 | Glioma | 0.452808 | 30 |
| 05212 | Pancreatic cancer | 05215 | Prostate cancer | 0.445505 | 35 |
| 04012 | ErbB signaling pathway | 05221 | Acute myeloid leukemia | 0.438825 | 32 |
| 04722 | Neurotrophin signaling pathway | 05214 | Glioma | 0.425391 | 40 |
| 05214 | Glioma | 05221 | Acute myeloid leukemia | 0.421118 | 26 |
| 05212 | Pancreatic cancer | 05221 | Acute myeloid leukemia | 0.417586 | 26 |
| 04012 | ErbB signaling pathway | 04722 | Neurotrophin signaling pathway | 0.416569 | 44 |
| 04722 | Neurotrophin signaling pathway | 05220 | Chronic myeloid leukemia | 0.375176 | 37 |
| 00071 | Fatty acid degradation | 00280 | Valine, leucine and isoleucine degradation | 0.369459 | 17 |
| 04012 | ErbB signaling pathway | 04910 | Insulin signaling pathway | 0.369013 | 43 |
| 04012 | ErbB signaling pathway | 05215 | Prostate cancer | 0.366904 | 33 |
| 04722 | Neurotrophin signaling pathway | 04910 | Insulin signaling pathway | 0.333639 | 45 |
| 04910 | Insulin signaling pathway | 04930 | Type II diabetes mellitus | 0.333501 | 32 |
| 04910 | Insulin signaling pathway | 05214 | Glioma | 0.332856 | 35 |
| 04012 | ErbB signaling pathway | 05212 | Pancreatic cancer | 0.332587 | 26 |
| 04722 | Neurotrophin signaling pathway | 05223 | Nonsmall cell lung cancer | 0.322021 | 29 |
| 04910 | Insulin signaling pathway | 05220 | Chronic myeloid leukemia | 0.319142 | 35 |
| 04012 | ErbB signaling pathway | 04510 | Focal adhesion | 0.307397 | 47 |
| 04722 | Neurotrophin signaling pathway | 05215 | Prostate cancer | 0.305474 | 33 |
| 04722 | Neurotrophin signaling pathway | 05221 | Acute myeloid leukemia | 0.297190 | 27 |
| 04910 | Insulin signaling pathway | 05221 | Acute myeloid leukemia | 0.296282 | 30 |
| 00071 | Fatty acid degradation | 03320 | PPAR signaling pathway | 0.295383 | 17 |
| 04722 | Neurotrophin signaling pathway | 05212 | Pancreatic cancer | 0.281428 | 27 |
| 04510 | Focal adhesion | 05214 | Glioma | 0.261438 | 37 |
| 04910 | Insulin signaling pathway | 05215 | Prostate cancer | 0.259024 | 31 |
| 04910 | Insulin signaling pathway | 05223 | Nonsmall cell lung cancer | 0.256664 | 26 |
| 04062 | Chemokine signaling pathway | 05220 | Chronic myeloid leukemia | 0.255785 | 35 |
| 03320 | PPAR signaling pathway | 04920 | Adipocytokine signaling pathway | 0.251432 | 18 |
| 04062 | Chemokine signaling pathway | 04722 | Neurotrophin signaling pathway | 0.249358 | 41 |
| 04910 | Insulin signaling pathway | 04920 | Adipocytokine signaling pathway | 0.246928 | 27 |
| 04510 | Focal adhesion | 05215 | Prostate cancer | 0.243062 | 38 |
| 04930 | Type II diabetes mellitus | 05212 | Pancreatic cancer | 0.239467 | 14 |
| 04012 | ErbB signaling pathway | 04062 | Chemokine signaling pathway | 0.233097 | 34 |
| 04510 | Focal adhesion | 04722 | Neurotrophin signaling pathway | 0.227594 | 40 |
| 04062 | Chemokine signaling pathway | 05221 | Acute myeloid leukemia | 0.225918 | 29 |
| 04930 | Type II diabetes mellitus | 05221 | Acute myeloid leukemia | 0.222682 | 12 |
| 04910 | Insulin signaling pathway | 05212 | Pancreatic cancer | 0.213040 | 23 |
| 04510 | Focal adhesion | 05223 | Nonsmall cell lung cancer | 0.210418 | 29 |
| 00010 | Glycolysis / Gluconeogenesis | 00071 | Fatty acid degradation | 0.210120 | 12 |
| 04110 | Cell cycle | 05220 | Chronic myeloid leukemia | 0.202547 | 21 |
| 04062 | Chemokine signaling pathway | 05214 | Glioma | 0.201371 | 27 |
| 04510 | Focal adhesion | 05212 | Pancreatic cancer | 0.200829 | 29 |
| 04062 | Chemokine signaling pathway | 05212 | Pancreatic cancer | 0.200395 | 27 |
| 04012 | ErbB signaling pathway | 04930 | Type II diabetes mellitus | 0.200216 | 14 |
| 04062 | Chemokine signaling pathway | 04510 | Focal adhesion | 0.199227 | 44 |
| 04920 | Adipocytokine signaling pathway | 04930 | Type II diabetes mellitus | 0.196741 | 12 |
| 04062 | Chemokine signaling pathway | 05215 | Prostate cancer | 0.194466 | 29 |
| 04062 | Chemokine signaling pathway | 04910 | Insulin signaling pathway | 0.193923 | 35 |
| 04510 | Focal adhesion | 04910 | Insulin signaling pathway | 0.193683 | 37 |
| 04630 | JAK-STAT signaling pathway | 05220 | Chronic myeloid leukemia | 0.189152 | 23 |
| 04930 | Type II diabetes mellitus | 05214 | Glioma | 0.188174 | 11 |
| 04510 | Focal adhesion | 05220 | Chronic myeloid leukemia | 0.187250 | 28 |
| 04930 | Type II diabetes mellitus | 05223 | Nonsmall cell lung cancer | 0.186194 | 10 |
| 04062 | Chemokine signaling pathway | 05223 | Nonsmall cell lung cancer | 0.185694 | 24 |
| 04930 | Type II diabetes mellitus | 05215 | Prostate cancer | 0.182369 | 13 |
| 04722 | Neurotrophin signaling pathway | 04930 | Type II diabetes mellitus | 0.182330 | 16 |
| 04630 | JAK-STAT signaling pathway | 05221 | Acute myeloid leukemia | 0.177817 | 20 |
| 04930 | Type II diabetes mellitus | 05220 | Chronic myeloid leukemia | 0.174873 | 11 |
| 00071 | Fatty acid degradation | 04920 | Adipocytokine signaling pathway | 0.168912 | 10 |
| 04920 | Adipocytokine signaling pathway | 05212 | Pancreatic cancer | 0.168257 | 12 |
| 04510 | Focal adhesion | 05221 | Acute myeloid leukemia | 0.155698 | 22 |
| 04110 | Cell cycle | 04350 | TGF-beta signaling pathway | 0.154720 | 17 |
| 04012 | ErbB signaling pathway | 04630 | JAK-STAT signaling pathway | 0.150823 | 20 |
| 04920 | Adipocytokine signaling pathway | 05221 | Acute myeloid leukemia | 0.149712 | 10 |
| 04110 | Cell cycle | 05212 | Pancreatic cancer | 0.147216 | 15 |
| 04722 | Neurotrophin signaling pathway | 04920 | Adipocytokine signaling pathway | 0.136266 | 14 |
| 04020 | Calcium signaling pathway | 05214 | Glioma | 0.134931 | 18 |
| 04630 | JAK-STAT signaling pathway | 05212 | Pancreatic cancer | 0.132448 | 16 |
| 04630 | JAK-STAT signaling pathway | 05223 | Nonsmall cell lung cancer | 0.131103 | 15 |
| 04920 | Adipocytokine signaling pathway | 05220 | Chronic myeloid leukemia | 0.130829 | 10 |
| 04350 | TGF-beta signaling pathway | 05212 | Pancreatic cancer | 0.127816 | 10 |
| 04110 | Cell cycle | 05215 | Prostate cancer | 0.127707 | 15 |
| 04630 | JAK-STAT signaling pathway | 05215 | Prostate cancer | 0.124352 | 17 |
| 04630 | JAK-STAT signaling pathway | 05214 | Glioma | 0.124065 | 15 |
| 04630 | JAK-STAT signaling pathway | 04910 | Insulin signaling pathway | 0.123086 | 21 |
| 04350 | TGF-beta signaling pathway | 05220 | Chronic myeloid leukemia | 0.120966 | 10 |
| 04920 | Adipocytokine signaling pathway | 05215 | Prostate cancer | 0.115713 | 10 |
| 00010 | Glycolysis / Gluconeogenesis | 04930 | Type II diabetes mellitus | 0.114537 | 7 |
| 00010 | Glycolysis / Gluconeogenesis | 04910 | Insulin signaling pathway | 0.113934 | 13 |
| 04630 | JAK-STAT signaling pathway | 04930 | Type II diabetes mellitus | 0.108132 | 12 |
| 04110 | Cell cycle | 05214 | Glioma | 0.105312 | 11 |
| 04020 | Calcium signaling pathway | 04310 | Wnt signaling pathway | 0.104504 | 20 |
| 04012 | ErbB signaling pathway | 04310 | Wnt signaling pathway | 0.100507 | 13 |
| 04062 | Chemokine signaling pathway | 04930 | Type II diabetes mellitus | 0.099688 | 13 |
| 00010 | Glycolysis / Gluconeogenesis | 00280 | Valine, leucine and isoleucine degradation | 0.098022 | 6 |
| 04062 | Chemokine signaling pathway | 04630 | JAK-STAT signaling pathway | 0.093423 | 20 |
| 04510 | Focal adhesion | 04930 | Type II diabetes mellitus | 0.091674 | 13 |
| 04630 | JAK-STAT signaling pathway | 04722 | Neurotrophin signaling pathway | 0.090770 | 15 |
| 04110 | Cell cycle | 05223 | Nonsmall cell lung cancer | 0.089793 | 9 |
| 04920 | Adipocytokine signaling pathway | 05223 | Nonsmall cell lung cancer | 0.086981 | 6 |
| 04310 | Wnt signaling pathway | 05212 | Pancreatic cancer | 0.085159 | 10 |
| 04310 | Wnt signaling pathway | 04722 | Neurotrophin signaling pathway | 0.082773 | 13 |
| 04012 | ErbB signaling pathway | 04020 | Calcium signaling pathway | 0.081722 | 13 |
| 04110 | Cell cycle | 04310 | Wnt signaling pathway | 0.080919 | 13 |
| 04062 | Chemokine signaling pathway | 04920 | Adipocytokine signaling pathway | 0.078990 | 12 |
| 04012 | ErbB signaling pathway | 04920 | Adipocytokine signaling pathway | 0.078784 | 7 |
| 04310 | Wnt signaling pathway | 04350 | TGF-beta signaling pathway | 0.077256 | 10 |
| 04310 | Wnt signaling pathway | 05214 | Glioma | 0.075883 | 9 |
| 04310 | Wnt signaling pathway | 04510 | Focal adhesion | 0.075541 | 17 |
| 04310 | Wnt signaling pathway | 04330 | Notch signaling pathway | 0.075502 | 8 |
| 04310 | Wnt signaling pathway | 05215 | Prostate cancer | 0.072669 | 10 |
| 04020 | Calcium signaling pathway | 04910 | Insulin signaling pathway | 0.072522 | 15 |
| 04510 | Focal adhesion | 04630 | JAK-STAT signaling pathway | 0.069606 | 17 |
| 04020 | Calcium signaling pathway | 04722 | Neurotrophin signaling pathway | 0.067145 | 13 |
| 04020 | Calcium signaling pathway | 04062 | Chemokine signaling pathway | 0.067143 | 17 |
| 04630 | JAK-STAT signaling pathway | 04920 | Adipocytokine signaling pathway | 0.066537 | 9 |
| 04350 | TGF-beta signaling pathway | 05221 | Acute myeloid leukemia | 0.063936 | 5 |
| 00010 | Glycolysis / Gluconeogenesis | 04920 | Adipocytokine signaling pathway | 0.063675 | 5 |
| 04062 | Chemokine signaling pathway | 04310 | Wnt signaling pathway | 0.063207 | 14 |
| 00280 | Valine, leucine and isoleucine degradation | 03320 | PPAR signaling pathway | 0.061337 | 4 |
| 04310 | Wnt signaling pathway | 05221 | Acute myeloid leukemia | 0.059998 | 7 |
| 04330 | Notch signaling pathway | 05220 | Chronic myeloid leukemia | 0.058187 | 4 |
| 03320 | PPAR signaling pathway | 05223 | Nonsmall cell lung cancer | 0.055513 | 4 |
| 04310 | Wnt signaling pathway | 05220 | Chronic myeloid leukemia | 0.052512 | 7 |
| 04920 | Adipocytokine signaling pathway | 05214 | Glioma | 0.049949 | 4 |
| 04012 | ErbB signaling pathway | 04350 | TGF-beta signaling pathway | 0.048351 | 5 |
| 04020 | Calcium signaling pathway | 05223 | Nonsmall cell lung cancer | 0.047497 | 7 |
| 04020 | Calcium signaling pathway | 04930 | Type II diabetes mellitus | 0.042080 | 6 |
| 04310 | Wnt signaling pathway | 05223 | Nonsmall cell lung cancer | 0.039858 | 5 |
| 04350 | TGF-beta signaling pathway | 04930 | Type II diabetes mellitus | 0.038491 | 3 |
| 04310 | Wnt signaling pathway | 04910 | Insulin signaling pathway | 0.037561 | 8 |
| 04110 | Cell cycle | 04330 | Notch signaling pathway | 0.036823 | 4 |
| 04350 | TGF-beta signaling pathway | 05215 | Prostate cancer | 0.035527 | 4 |
| 04012 | ErbB signaling pathway | 04110 | Cell cycle | 0.033022 | 5 |
| 04020 | Calcium signaling pathway | 04510 | Focal adhesion | 0.029693 | 11 |
| 04510 | Focal adhesion | 04920 | Adipocytokine signaling pathway | 0.028550 | 6 |
| 03320 | PPAR signaling pathway | 04910 | Insulin signaling pathway | 0.025182 | 4 |
| 04110 | Cell cycle | 04630 | JAK-STAT signaling pathway | 0.023244 | 6 |
| 04330 | Notch signaling pathway | 04350 | TGF-beta signaling pathway | 0.022730 | 2 |
| 04110 | Cell cycle | 05221 | Acute myeloid leukemia | 0.022049 | 3 |
| 04350 | TGF-beta signaling pathway | 04910 | Insulin signaling pathway | 0.021892 | 4 |
| 04310 | Wnt signaling pathway | 04930 | Type II diabetes mellitus | 0.021752 | 3 |
| 04330 | Notch signaling pathway | 05215 | Prostate cancer | 0.020317 | 2 |
| 04350 | TGF-beta signaling pathway | 05223 | Nonsmall cell lung cancer | 0.020029 | 2 |
| 00010 | Glycolysis / Gluconeogenesis | 03320 | PPAR signaling pathway | 0.019725 | 2 |
| 04310 | Wnt signaling pathway | 04630 | JAK-STAT signaling pathway | 0.019514 | 6 |
| 04350 | TGF-beta signaling pathway | 04630 | JAK-STAT signaling pathway | 0.018819 | 4 |
| 04350 | TGF-beta signaling pathway | 04510 | Focal adhesion | 0.018382 | 5 |
| 04350 | TGF-beta signaling pathway | 05214 | Glioma | 0.017344 | 2 |
| 04350 | TGF-beta signaling pathway | 04722 | Neurotrophin signaling pathway | 0.016276 | 3 |
| 04110 | Cell cycle | 04722 | Neurotrophin signaling pathway | 0.015333 | 4 |
| 04310 | Wnt signaling pathway | 04920 | Adipocytokine signaling pathway | 0.015212 | 3 |